» Articles » PMID: 37539610

Proposal for a New Diagnostic-therapeutic Algorithm in Chronic Rhinosinusitis with Nasal Polyps

Overview
Journal Acta Biomed
Specialty General Medicine
Date 2023 Aug 4
PMID 37539610
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic inflammatory disease of the nose and the paranasal sinuses characterized by the presence of nasal polyps and persistent symptoms of nasal obstruction, anterior or posterior rhinorrhea, facial pain or pressure, and reduction or loss of smell, lasting longer than 12 weeks. Several therapeutic strategies are nowadays available to treat CRSwNP as a function of disease severity. However, a standardized therapeutic algorithm has not yet been proposed. Since CRSwNP severity can be assessed by the Clinical-Cytological Grading (CCG) and the consequent reduction in patients' Quality of Life can be defined with the Sino Nasal Outcome Test-22 (SNOT-22), we aimed to propose a new diagnostic-therapeutic algorithm, that takes into consideration both the characteristics of the patients, including the CCG, nasal obstruction, and SNOT-22, and all the therapies available today.

Citing Articles

The Potential Role of Nasal Cytology in Respiratory Diseases: Clinical Research and Future Perspectives.

Marcuccio G, Raffio G, Ambrosino P, Candia C, Cantone E, Detoraki A J Clin Med. 2025; 14(3).

PMID: 39941555 PMC: 11818278. DOI: 10.3390/jcm14030884.


A Comparison of Tranexamic Acid in Nasal Versus Sinus Surgeries: a Systematic Review and Meta-Analysis.

Teng T, Chia A, Gan K, Tan L, Wang Y, Charn T Indian J Otolaryngol Head Neck Surg. 2024; 76(4):3018-3030.

PMID: 39130301 PMC: 11306473. DOI: 10.1007/s12070-024-04579-x.


Endotyping Chronic Respiratory Diseases: T2 Inflammation in the United Airways Model.

Ambrosino P, Marcuccio G, Raffio G, Formisano R, Candia C, Manzo F Life (Basel). 2024; 14(7).

PMID: 39063652 PMC: 11278432. DOI: 10.3390/life14070899.

References
1.
De Corso E, Bilo M, Matucci A, Seccia V, Braido F, Gelardi M . Personalized Management of Patients with Chronic Rhinosinusitis with Nasal Polyps in Clinical Practice: A Multidisciplinary Consensus Statement. J Pers Med. 2022; 12(5). PMC: 9143504. DOI: 10.3390/jpm12050846. View

2.
Stevens W, Peters A, Tan B, Klingler A, Poposki J, Hulse K . Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis. J Allergy Clin Immunol Pract. 2019; 7(8):2812-2820.e3. PMC: 6842686. DOI: 10.1016/j.jaip.2019.05.009. View

3.
Shaghayegh G, Cooksley C, Ramezanpour M, Wormald P, Psaltis A, Vreugde S . Chronic Rhinosinusitis, Biofilm and Secreted Products, Inflammatory Responses, and Disease Severity. Biomedicines. 2022; 10(6). PMC: 9220248. DOI: 10.3390/biomedicines10061362. View

4.
Schneider A, Racette S, Kang A, Reddy A, Huang J, Lehmann D . Use of intraoperative frontal sinus mometasone-eluting stents decreased interleukin 5 and interleukin 13 in patients with chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2022; 12(11):1330-1339. PMC: 9525456. DOI: 10.1002/alr.23005. View

5.
Husain Q, Hoehle L, Phillips K, Caradonna D, Gray S, Sedaghat A . The 22-Item Sinonasal Outcome Test as a Tool for the Assessment of Quality of Life and Symptom Control in Allergic Rhinitis. Am J Rhinol Allergy. 2019; 34(2):209-216. DOI: 10.1177/1945892419884789. View